Intrinsic Value

Is CHEK undervalued or overvalued?

See the intrinsic value estimate for Diastika Biotekindo Tbk PT and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

CHEK Intrinsic Value
LOCKED
Unlock
Today vs. history

CHEK looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with CHEK’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor CHEK
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price Rp120
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CHEK

Fundamental Analysis

What Diastika Biotekindo Tbk PT Does

Health Care

PT Diastika Biotekindo Tbk sells laboratory and diagnostic products used by hospitals, clinics, universities, research labs, and industrial customers in Indonesia. Its business is centered on supplying testing tools, reagents, and related lab equipment that help customers analyze samples, run diagnostics, and support quality control work.

Headquarters
Indonesia ID
Employees
106
IPO date
Jul 10, 2025
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Diastika Biotekindo Tbk PT

Efficiency

Earnings Waterfall
Diastika Biotekindo Tbk PT

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one CHEK stock?

The intrinsic value for Diastika Biotekindo Tbk PT (CHEK) under the Base Case is hidden IDR.

Is CHEK stock undervalued or overvalued?

Compared with the current market price of 120 IDR, the stock appears hidden.

Back to Top